Clinical trial Recruiting at 1 site Observational Ages 18 to 70

Examining Salivary Cytokine Levels in Different Periodontal Conditions

Official title: Evaluation of Salivary Granulocyte-Macrophage Colony-Stimulating Factor, Macrophage Inflammatory Protein and Interleukin-1β Levels in Individuals With Different Periodontal Conditions

Run by Izmir Katip Celebi University · NCT06961409 · Data updated 2026-11-12

This study is trying to see if the levels of certain proteins in saliva can help us understand the differences in gum health between people with healthy gums, gingivitis, and periodontitis.

More Periodontitis trials

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment60 (estimated)
SponsorIzmir Katip Celebi University
Academic / other
Locations1 site (Izmir, Çiğli)
StatusRecruiting
StartedAugust 14, 2024
Main results expectedAugust 1, 2025
Study endsOctober 1, 2025
Registry record updatedMay 7, 2025
Trial IDNCT06961409 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are systemically healthy individuals with at least twenty permanent teeth, who are non-smokers and have not received periodontal treatment in the last six months.

Probably not a fit

Patients with systemic diseases, those on regular medications, pregnant or breastfeeding women, and smokers may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the levels of specific cytokines, including GM-CSF, MIP-1α, and IL-1β, in the saliva of individuals with varying periodontal conditions: healthy gums, gingivitis, and periodontitis. A total of 60 systemically healthy participants will be recruited, with saliva samples collected and analyzed using enzyme-linked immunoassay (ELISA) to determine the inflammatory biomarkers present. The study seeks to understand the relationship between these cytokines and the pathogenesis of chronic inflammatory periodontal diseases.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of periodontal disease mechanisms and lead to improved diagnostic and therapeutic strategies for patients.

How similar studies have gone: While the specific cytokine analysis in saliva for periodontal conditions may be novel, similar studies have shown the importance of cytokines in understanding inflammatory diseases.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Systemically healthy participants.
* At least twenty permanent teeth present in the oral cavity.
* Non-smokers.
* No medication for continuous use.
* Not pregnant or breastfeeding.

Exclusion Criteria:

* Any oral or systemic disease.
* Regular use of systemic medications.
* Pregnancy or lactation.
* Received periodontal treatment within the last 6 months.
* Use of antibiotics, anti-inflammatory medications, or systemic corticosteroids in the last 6 months.
* Smokers.

Where it's running

  • Izmir Katip Çelebi University Department of Periodontology
    Izmir, Çiğli, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.